Patient Reflection on Research: The Bronchiectasis Exacerbation Diary
[et_pb_section fb_built="1" theme_builder_area="post_content" _builder_version="4.24.2" _module_preset="default"][et_pb_row _builder_version="4.24.2" _module_preset="default" theme_builder_area="post_content"][et_pb_column _builder_version="4.24.2" _module_preset="default" type="4_4" theme_builder_area="post_content"][et_pb_text _builder_version="4.24.2" _module_preset="default" theme_builder_area="post_content" hover_enabled="0" sticky_enabled="0"]
Navigating the rollercoaster of chronic illness is a unique and often isolating experience. It is a journey that can be filled with uncertainties, regular hospital appointments, and a never-ending quest for a return to normal. This is so often the reality for individuals with chronic respiratory diseases, such as aspergillosis.
In this post, Evelyn embarks on a reflective journey, chronicling the evolution of her illness from childhood diagnosis to the present day, a timeline characterised by bilateral severe cystic bronchiectasis complicated by the colonisation of aspergillus and the less common scedosporium. For Evelyn, keeping a diary, noting symptoms, infections, and treatment strategies has been a way to make sense of the unpredictability of her health. This habit, instilled years ago by a forward-thinking consultant, transcends its practical utility, evolving into a critical tool for patient empowerment and self-advocacy.
When searching the web for help refining her symptom diary, Evelyn came across a paper titled: The Bronchiectasis Exacerbation Diary. This paper was a revelation of sorts. It cast light on often-overlooked aspects of the patient-experience and validated the often inexplicable symptoms that Evelyn experiences. It is evidence as to the power of patient-centered research and the impact of seeing lived experience acknowledged in scientific literature.
Evelyn's below reflection is a reminder of the broader implications of chronic illness on daily life and the need to adapt to navigate daily life.
As a result of a conversation with Lauren recently concerning the use of a symptom diary/journal, I came across a paper published on the internet, ‘The Bronchiectasis Exacerbation Diary’. Diagnosed in childhood with a chronic respiratory disease which has progressed throughout my life, I have bilateral severe cystic bronchiectasis with colonisation of aspergillus and the rarer fungi, scedosporium.
I have long been accustomed to keeping notes of symptoms/infections/treatment, having been encouraged to do so, many years ago, by a consultant for ease of reference at appointments. He emphasised treating infections should be dependent on the result of a sputum culture and sensitivity and not on a “Russian roulette” approach, as he called broad spectrum antibiotics; without knowing what type of infection was involved. Thankfully, my GP was co-operative, as at that time cultures were not routine. (I had dreaded acquiring a reputation as a bolshie patient!)
Reading the above mentioned paper was a revelation. It brought together the range of symptoms I experience daily, even some symptoms I felt were not appropriate to mention at clinic consultations. Moreover, I felt validated.
There have been occasions, albeit rarely, when I have doubted myself, none more so than when one clinician inferred I was psychosomatic. This was my lowest point. Thankfully, following this I was referred to a respiratory physician at Wythenshawe Hospital who, when a culture showed aspergillus, transferred me to Professor Denning’s care; as they say “every cloud has a silver lining”. Aspergillus had previously been found in a culture at another hospital in 1995/6, but not treated in the way it was at Wythenshawe.
Not only everyday symptoms were considered in the article, but also the immediate impact patients’ experience with daily living. Also, in a wider sense, the general impacts on our lives and the adjustments we all face in coping – all of which I can so easily identify with in my own life.
I felt so encouraged reading the paper as despite all of the various types of patient information leaflets I have read through the years, none were so comprehensive.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
Empowering Patients through Understanding Professional Medical Guidelines
[et_pb_section fb_built="1" _builder_version="4.24.0" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_row _builder_version="4.24.0" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_column type="4_4" _builder_version="4.24.0" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_text _builder_version="4.24.0" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"]
Navigating the healthcare landscape can be daunting for patients and their families, especially when dealing with complex lung conditions like aspergillosis. Understanding medical jargon and diagnostic and treatment paths is often overwhelming. This is where the European Lung Foundation (ELF) can help with its initiative to demystify professional medical guidelines.
The Importance of Lay Versions of Guidelines
The ERS provides detailed clinical guidelines for healthcare professionals, outlining the best practices in the diagnosis, management, and treatment of various lung conditions. However, these documents are often technical and challenging for non-clinical people to understand. Recognising this gap, the ELF has produced lay versions of these guidelines. These simplified versions can help support patient education and empower individuals to understand their health conditions better.
Why Patients Should Utilise These Guidelines:
- Enhanced Patient Engagement: Understanding these guidelines enables patients to actively participate in their healthcare decisions.
- Improved Communication with Clinicians: Patients who understand the guidelines can communicate more effectively with their doctors, leading to better healthcare outcomes.
- Empowerment in Managing Health: Knowledge of treatment standards and protocols allows patients to advocate for their health and ensures they receive the best possible care.
The Role of Guidelines in Healthcare
Clinical guidelines are vital in ensuring consistency and quality in healthcare. They provide a framework for healthcare professionals to deliver the most effective treatments based on the latest research and best practices.
The ELF's effort in translating professional guidelines into layman's terms is a commendable step towards patient empowerment. By understanding these guidelines, patients and their caregivers can navigate the healthcare system more effectively, ensuring they receive the best possible care for their lung conditions.
We encourage patients, their carers and families to explore these resources provided by the European Lung Foundation to better understand their health conditions and treatment options.
You can access the guidelines by visiting here.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
ELF holds their first Breathe Clean Air patient conference
Last week the European Lung Foundation held their first Air Pollution and Climate Change patient conference, where people came together to share personal experiences and hear about the latest research. All recordings are available to watch on demand via their YouTube channel, including moving personal stories from Tessa Jelen (Breathe Easy Westminster) and Rosamund Adoo-Kissi-Debrah (mother of Ella Roberta)
This will hopefully be the first in a series, so keep watching their website for dates of future meetings (it’s free and online). ELF organise many patient advocacy activities and also hold patient conferences for topics such as bronchiectasis, pulmonary fibrosis and asthma.
How can we improve indoor air quality at home?
Many aspergillosis patients find their symptoms are aggravated by poor air quality within the home, especially if they have related conditions such as asthma or COPD. Cigarette smoke and damp/mould are obvious sources, but problems can also be caused by the products we use to keep our homes smelling nice.
Triggers vary greatly from person to person and the scientific data on this subject is currently quite incomplete, so people are often not believed. Family, friends and even shops can be very reluctant to believe that their air fresheners and scented candles could be harmful. If you have problems with family and friends doubting, try sharing this infographic
- Damp and mould are hazardous to health and should be minimised for everyone, particularly children and those with lung conditions. NICE (NHS) issued guidelines for professionals in 2021 that give specific recommendations for doctors, construction and local authorities. Shelter provide a guide for people living in damp rentals or council housing.
- Gas cookers release particulates that should be removed by using an extraction fan (remember to change the filter regularly!) and opening a window for 10 minutes after cooking. If you are replacing your cooker, consider switching to electric/induction hob
- Scented candles and incense produce large amounts of particulates and should not be used regularly, especially in small, poorly-ventilated rooms like bathrooms
- Volatile organic compounds (VOCs) can be found in cleaning products and deodorant sprays
How can we improve outdoor air quality for everyone?
Unfortunately many aspects of air pollution are beyond our individual control, so it is also important for lung patients to come together and advocate for better laws and protections.
- Attend future ELF patient conferences
- Get involved in Healthy Lungs for Life
- Become an ELF clean air advocate
- Watch out for ELF activities at the European Respiratory Society medical conference (Sep 2024)
- Follow ELF on X (formerly Twitter)
Thoughts on the Aspergillosis Journey Five Years On - November 2023
[et_pb_section fb_built="1" theme_builder_area="post_content" _builder_version="4.23.1" _module_preset="default"][et_pb_row _builder_version="4.23.1" _module_preset="default" theme_builder_area="post_content" custom_margin="50px|auto|50px|61px|true|false" custom_padding="0px|1px|0px|0px|false|false" width="90.7%"][et_pb_column _builder_version="4.23.1" _module_preset="default" type="4_4" theme_builder_area="post_content"][et_pb_text _builder_version="4.23.1" _module_preset="default" theme_builder_area="post_content" hover_enabled="0" sticky_enabled="0" width="99.9%"]
Alison Heckler ABPA
I have written about the initial journey and diagnosis before, but the ongoing Journey occupies my thoughts these days. From a Lung/Aspergillosis/ Breathing perspective, now that we are coming into summer in New Zealand, I feel I’m doing ok, looking and feeling well.
Some of my current Medical Background:-
I started the biologic, mepolizumab (Nucala), in September 2022 after a really difficult 12 months (another story). By Christmas, I was much improved and, from a breathing and energy perspective, had a good summer; although the weather was so bad, it was hardly a summer.
I got complacent about precautions, and in early February, a grandson visited with what turned out to be a nasty flu that I then went down with. 6 weeks later, a follow-up X-ray on the lungs showed a heart issue that needed a cardiologist to check “well the aortic stenosis isn’t a big worry but the aortic duct never healed over as a child. We could repair but …..” the answer to that was “I’m over 70, had four pregnancies, I’m still here & the risk factors with all my other issues ….. not going to happen”
Once finally over those two hiccups, my 81-year-old sister was admitted to the hospital, and I was trying to advocate for her. She got Covid, which I subsequently got from her. (I had done well to stay Covid Free for 2.5 years). But yet again, any infection I get these days takes much longer to recover from; I still had it at four weeks, and at 6-8 weeks, my GP was concerned that I might have developed Long Covid as my BP and heart rate were still a bit on the high side! My sister was diagnosed with Myeloma and died within six weeks of diagnosis.
Since starting the Mepolizumab, I had noticed increasing problems with incontinence, and this developed in a full-blown Pyelonephritis (eColi Kidney Infection). As I only have one kidney, the anxiety level over this was a bit high as the symptoms were/are all very similar to when my other kidney was eventually removed. (No plan B here). Toss-up: able to breathe versus learning to deal with some incontinence?
I overlay all of 2023 with ongoing Mental Health issues with my 13-14-year-old granddaughter, so my daughter and her husband, on whose property I live, were totally preoccupied with trying to keep her safe and all the care that she requires. We are all grieving the loss of this child who is now in care.
Pain levels are high, and energy levels are very low. Prednisone has essentially killed my cortisol production, so I have Secondary Adrenal Insufficiency and Osteoporosis.
But I am Thankful
I am so grateful that I am blessed to live in a country that has a Public Health System (be it a similarly crumbling one as NHS). I was able to move to an area that has a good teaching hospital and be close to my daughter (Palliative Care physician) & her husband (Anaesthetist), I have access to free public health medications and an excellent GP who listens, looks at the whole picture and does her best to get all the Specialist to review the situation. Recent x-rays and Dexta Scan revealed the extent of the damage and deterioration of the spin: Info I need to bring to the attention of the Physio who is trying to help with my motivation/activation of strengthening exercises. Endocrinology suggested a 5mg increase in my hydrocortisone and a pushing out of the dose timing, and that has made a HUGE difference in how I cope with dealing with all that is going on and the pain. Urology has finally accepted a referral to review my kidney situation, although it still might be a few months before they see me. A recent checkup with the Physio found that the exercises had made a difference, and I was considerably stronger in my legs. I still struggle to do these, but this information informs me that I need to persist.
The Biggest Battle is Mental Attitude
Each of our stories will be unique, and for each of us, the battle is real. (When I write mine all down, it does sound a bit overwhelming, but generally, I don’t think of it in that way. I have shared my story only as an example of the complexity of the journey.)
How do we cope with all of the changes that come upon us? I knew that my health would change as I got older, but I feel like it has come upon me so rapidly. I didn’t think of myself as old, but my body is most definitely thinking and behaving that way!
Learning to:
Accept the things I cannot change,
to Work on the things I can change,
And the wisdom to know the difference
This process of letting go of dreams and hopes and setting new, more modest goals has been important. I have learned that after a more strenuous activity (by my current abilities), I have to sit down and rest or do something that allows me to rest and be productive. I have previously been somewhat of a ‘workaholic’ and not much of a planner, so this transition has not been easy. All of these changes are a Grieving Process, and like any grief, we heal better if we acknowledge it for what it is, then we can learn to live with our grief. We can move forward into all the ‘new normals’. I now have a planning diary with notes on what I want/need to do, but it is not planned out in detail as I have to “go with the flow” as it were on how much energy I have available to get things done. The reward is that I will eventually get things ticked off. If it’s only 1 or 2 daily tasks, that’s ok.
When I finally got a diagnosis in 2019, I was told that “it was not lung cancer; it was ABPA, which is chronic and incurable but could be managed”. What ‘be managed’ entailed, I most definitely did not take in at the time. Every medication that we take is going to have a side effect; antifungals and prednisone are way up there in that respect, and it is sometimes the side issues that are more difficult to cope with. Mentally, I have to remind myself that I can breathe and haven’t died of secondary pneumonia because of the meds that keep the aspergillosis under control. I am alive because I manage my intake of Hydrocortisone every day.
Weighing up the benefits versus the side effects. There are some medications that once I studied the side effects and contraindications and weighed that info against the benefits for relieving Peripheral Neuropathy, I consulted with a Dr, and we dropped it. Other medications do have to stay, and you learn to live with the irritations (rashes, dry skin, extra back pain, etc.). Again, we are each unique in what we can manage, and sometimes, it is the attitude (stubbornness) with which we approach the situation that will determine our direction.
A note on stubborn…. Last year, I set myself the goal of getting my daily average walking distance back up to 3k per day. It was a bit of a mission when some days I wasn’t reaching 1.5K. Today, I managed a 4.5 flat walk on the beach and, more importantly, saw the daily average over the past 12 months get to 3k per day. So, I celebrate a win for as long as it lasts. I make clip-on pouches for my iPhone so that I always carry it to record my steps, and I recently purchased a Smart Watch that includes recording all my health data statistics. It is a new normal to track this stuff, and the NAC research Team is wondering if such data could help us predict ABPA flares etc.
For me, my faith in the sovereignty of God is paramount in keeping me focused and moving forward.
“He knit me together in my mother's womb. My days are ordered by his hand.” Psalm 139.
I have been saved by Grace, by Christ alone.
Yes, a number of my medical conditions could/will contribute to my death; we all die at some point, but I can live the best life I can now, knowing that God still has work for me to do.
“This world is not my home. I’m just a passing through.”
Talking with others on Teams Video and reading posts or stories on Facebook Support or the website all add to helping me keep positive. (At least most of the time) Hearing other people's stories helps to put my own back into perspective … I could be worse. So, as best I can, with the Lord’s help, I hope to encourage others to keep walking on the difficult road you sometimes find yourself on. Yes, it can be very difficult at times, but look at it as a new challenge. We are not promised an easy life.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
Do you have asthma and Allergic Bronchopulmonary Aspergillosis?
[et_pb_section fb_built="1" theme_builder_area="post_content" _builder_version="4.23" _module_preset="default"][et_pb_row _builder_version="4.23" _module_preset="default" theme_builder_area="post_content" width="91.8%"][et_pb_column _builder_version="4.23" _module_preset="default" type="4_4" theme_builder_area="post_content"][et_pb_text _builder_version="4.23" _module_preset="default" theme_builder_area="post_content" hover_enabled="0" sticky_enabled="0"]
We're excited to share that there's a new clinical study that's looking into an innovative treatment specifically for individuals dealing with both asthma and ABPA. This treatment comes in the form of an inhaler called PUR1900.
What is PUR1900?
PUR1900 is an inhaled medication that's being tested for its effectiveness against the symptoms of ABPA in asthma patients. It’s designed to deliver an antifungal medication directly to the lungs, where it can work right at the source of the problem.
The Study at a Glance
The study spans several months and is divided into three key phases:
- Screening Period (28 days): Researchers will do some tests to make sure this study is the right fit for you.
- Treatment Period (112 days): If you're eligible, you'll use the inhaler for about 16 weeks. You could receive either a higher dose, a lower dose of PUR1900, or a placebo (which doesn't contain the actual medication).
- Observation Period (56 days): After the treatment, researchers will keep an eye on your health for another 8 weeks.
What Will Participants Do?
- Daily Routines: You'll use the inhaler daily as directed and keep track of your experience in an electronic diary (eDiary).
- At-Home Checks: You'll measure your breathing strength daily using a simple device.
- Clinic Visits: Approximately once a month, you'll visit the clinic for check-ups and tests.
Why Participate?
By joining this study, you're not only potentially finding a new way to manage your asthma and ABPA, but you're also contributing to medical research that could help countless others in the future.
Safety and Benefits
Your safety is the top priority. You'll be closely monitored throughout the study, and all treatments will be provided at no cost to you. Plus, if you successfully complete the study, there may be an opportunity to continue receiving PUR1900 in a follow-up study.
Taking the Next Step
Researchers are looking for adults with asthma and ABPA who are interested in exploring this new treatment option. If you're ready to take the next step, eligibility and contact details on how you can participate in this groundbreaking study can be found by clicking here.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
The Marathon of Management: Steady Pacing Through Chronic Condition Flares
[et_pb_section fb_built="1" theme_builder_area="post_content" _builder_version="4.23" _module_preset="default"][et_pb_row _builder_version="4.23" _module_preset="default" theme_builder_area="post_content" width="93.3%"][et_pb_column _builder_version="4.23" _module_preset="default" type="4_4" theme_builder_area="post_content"][et_pb_text _builder_version="4.23" _module_preset="default" theme_builder_area="post_content" hover_enabled="0" sticky_enabled="0"]
Living with a chronic condition is like navigating a course with varied terrain. It's not a journey that will end in recovery in the conventional sense, as the condition itself persists. Instead, it is about managing the fluctuations—periods of stability interspersed with challenging exacerbations or complications like infections or additional illnesses.
In the world of distance running, there's a strategy known as "go slow to go fast." It's a principle that initially seems counterintuitive; to achieve speed and efficiency in a race, a runner must first invest time in slow, steady-paced training. But, in running, this approach builds a robust foundation of aerobic fitness, reducing injury risk and preparing the body for the demands of faster running in the future. In essence, "go slow to go fast" is not just about running—it's a metaphor for any process that requires building strength and resilience, one step at a time, and for individuals navigating the complexities of chronic conditions, adopting this philosophy could help manage their health over time by learning to listen to their body and respecting its need for gradual progression. Just as runners build their pace over time to avoid burnout, patients could benefit from looking at their journey with patience and persistence—understanding that managing a chronic condition often requires a slow and steady approach to maintain health and prevent exacerbations.
Setting Achievable Goals
After a flare-up, complications or other illnesses, it's important to reassess and set realistic goals tailored to current capabilities. Like a runner adjusting their training post-injury, patients must recalibrate their expectations and focus on attainable health milestones - no matter how small. Adapting goals accordingly can help to maintain progress without overstepping physical limits.
Crafting a Personalised Management Plan
Chronic conditions require a personalised management plan, one that considers the unpredictability and variability of symptoms. Drawing on a parallel with a runner's individualised training regime, patients can benefit from a bespoke plan that accommodates their fluctuating health, devised with input from healthcare professionals.
Embracing Consistency and Patience
Consistent management and the patience to accept slower progress at times are essential when living with a chronic condition, and symptoms will often present challenging days; finding strength in routine and maintaining a slow and steady approach on these days is important.
Recognising and Celebrating Progress
In the marathon that is chronic condition management, small victories can be profound. Celebrating the days when symptoms are managed effectively or when you can do that little bit more will bolster spirits and encourage continued effort.
Adjusting to Health Fluctuations
Just as a runner must listen to their body and adjust their training accordingly, patients with chronic conditions must remain flexible, adapting their management strategies in response to changes in their health - even if this means scaling back activities on a bad day.
Leaning on Your Support Team
The role of a support system is indispensable when living with a chronic illness. The encouragement from healthcare providers, family, and support groups can provide immense comfort and practical help during more challenging times.
Envisioning Your 'Finish Line'
While there may not be a traditional 'finish line' in chronic condition management, defining personal milestones and envisioning moments of reprieve can be incredibly motivating. Each phase of improved health or successful adaptation to a health challenge can be seen as its finish line, a testament to the patient's resilience.
The metaphor "go slow to go fast" transcends the realm of running. It can offer a powerful perspective for those managing chronic conditions like aspergillosis. It's a reminder that resilience often requires a measured approach, where understanding limits and gradually extending them is key to sustainable health management. This journey, punctuated by careful pacing and an awareness of our bodies, allows for periods of rest and recovery, which are just as important as the times of activity and progress. By embracing this principle, individuals can navigate their health challenges and build towards better days with confidence. While the finish line may differ in this marathon of management, each step taken at the right pace is a stride towards living a fuller life, regardless of the terrain ahead.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
Expanded NHS support available for patients in GP practices across the country
[et_pb_section fb_built="1" _builder_version="4.23" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_row _builder_version="4.23" _module_preset="default" width="93.9%" global_colors_info="{}" theme_builder_area="post_content"][et_pb_column type="4_4" _builder_version="4.23" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_text _builder_version="4.23" _module_preset="default" width="100%" hover_enabled="0" global_colors_info="{}" theme_builder_area="post_content" sticky_enabled="0"]
Did you know that a visit to your local GP practice now comes with an added layer of healthcare support? Under the newly rolled out GP Access Recovery Plan by the NHS, your local GP practice has additional healthcare staff and services designed to provide comprehensive care right in your community.
Here’s a breakdown of the new additions:
More Hands on Deck:
Since 2019, over 31,000 extra healthcare staff have joined general practices across the nation. This means besides your GP or practice nurse, there's now a diverse team of healthcare professionals, including pharmacists, mental health practitioners, paramedics, and physiotherapists, available to cater to your health needs.
Direct Access to Specialised Care:
When you contact your practice with a health issue, there’s a trained team ready to assess your needs and direct you to the right professional. For instance, if you have muscular pain, you’ll be booked to see a physiotherapist straight away.
No GP Referral? No Problem:
You don't always need a GP referral to see certain healthcare specialists. Now, you can get specialist support from mental health professionals, physios, and pharmacists without having to see a GP first. This is all about getting you the right care, faster.
Digital Doorway to Your GP:
32 million people use the NHS app to book appointments or check test results. This digital tool simplifies how you reach out to your GP, making healthcare access easier.
Social Prescribing for Holistic Care:
Social prescribing link workers can help with non-medical issues, like loneliness or financial advice. They even run community-based courses to impart new skills. For instance, in Nottingham, patients were able to learn cooking skills, opening doors to new opportunities.
Knowledge is Power:
A recent survey revealed that one in three people in England are still unaware of these upgraded services at their GP practice. Spreading the word ensures that more individuals can benefit from the expanded support available.
The enhanced support at GP practices is a significant stride towards creating a robust, community-centred healthcare system. It’s all about ensuring that you receive the right care, from the right professional, at the right time.
If you want to know more, visit nhs.uk/GPservices to explore the expanded services available at your GP practice.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
A Breath of Fresh Air: Repairing COPD Damage with Patients' Own Lung Cells
[et_pb_section fb_built="1" _builder_version="4.23" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_row _builder_version="4.23" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_column type="4_4" _builder_version="4.23" _module_preset="default" global_colors_info="{}" theme_builder_area="post_content"][et_pb_text _builder_version="4.23.1" _module_preset="default" hover_enabled="0" global_colors_info="{}" theme_builder_area="post_content" sticky_enabled="0"]
In a remarkable advancement towards treating Chronic Obstructive Pulmonary Disease (COPD), scientists have, for the first time, demonstrated the potential of repairing damaged lung tissue using patients' own lung cells. The breakthrough was unveiled at this year's European Respiratory Society International Congress in Milan, Italy, where results from a pioneering phase I clinical trial were shared.
COPD, which is common in those with chronic pulmonary aspergillosis (CPA), causes progressive damage to lung tissue, significantly impacting the quality of life for patients through the obstruction of airflow out of the lungs. The disease, claiming the lives of roughly 30,000 people in the UK each year, has been historically challenging to treat. Current treatments mainly focus on alleviating symptoms through bronchodilators such as salbutamol, which widen the airways to enhance airflow but do not repair the damaged tissue.
The search for a more definitive treatment led researchers to explore the realms of stem cell and progenitor cell-based regenerative medicine. Stem cells are known for their ability to morph into any cell type. Unlike stem cells, progenitor cells can only turn into certain types of cells related to a specific area or tissue. For example, a progenitor cell in the lung can turn into different types of lung cells but not into heart cells or liver cells. Among the researchers is Professor Wei Zuo from Tongji University, Shanghai and chief scientist at Regend Therapeutics. Professor Zuo and his team at Regend have been investigating a specific type of progenitor cell known as P63+ lung progenitor cells.
20 COPD patients were enrolled in the trial, 17 of whom received the cell treatment, while three served as the control group. The results were encouraging; the treatment was well tolerated, and patients exhibited improved lung function, could walk further, and reported a better quality of life following the treatment.
After 12 weeks of this new treatment, patients experienced a significant improvement in their lung function. Specifically, the lungs' ability to transfer oxygen and carbon dioxide to and from the bloodstream became more efficient. Additionally, patients could walk further during a standard six-minute walking test. The median (the middle number when all numbers are arranged from smallest to largest) distance increased from 410 meters to 447 meters - a good sign of improved aerobic capacity and endurance. Moreover, there was a notable decrease in the scores from the St George’s Respiratory Questionnaire (SGRQ), a tool used to measure the impact of respiratory diseases on overall quality of life. A lower score indicates that patients felt their quality of life had improved, with fewer symptoms and better daily functioning. Overall, this suggests that the treatment improved lung function and positively impacted patients' day-to-day lives.
The groundbreaking results also highlighted the potential of this treatment in repairing lung damage in patients with mild emphysema (a type of lung damage that occurs in COPD), a condition generally considered irreversible and progressive. Two patients enrolled on the trial with the condition showed resolution of the lesions at 24 weeks by CT imaging.
Endorsed by China's National Medical Products Administration (NMPA), which is the equivalent of the UK Medicines and Healthcare products Regulatory Agency (MHRA), a phase II clinical trial is in the pipeline to test further the use of P63+ progenitor cell transplantation in a larger group of COPD patients.
This innovation could significantly alter the course of treatment in COPD. Professor Omar Usmani of Imperial College London and Head of the European Respiratory Society group on airway disease, asthma, COPD and chronic cough provided his thoughts on the trial's significance, underscoring the urgent need for more effective treatments for COPD. He noted that if these results are confirmed in subsequent trials, it would be a major breakthrough in COPD treatment.
The road ahead appears promising, with the potential to not only alleviate the debilitating symptoms of COPD but to repair the damage it inflicts on the lungs, offering hope to millions suffering from this chronic respiratory disease.
You can read in more detail about the trial here: https://www.ersnet.org/news-and-features/news/transplanting-patients-own-lung-cells-offers-hope-of-cure-for-copd/
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
Empowering Yourself: Recognising Heart Attack Symptoms Could Be A Lifesaver
[et_pb_section fb_built="1" theme_builder_area="post_content" _builder_version="4.22.2" _module_preset="default"][et_pb_row _builder_version="4.22.2" _module_preset="default" theme_builder_area="post_content" custom_margin="50px|30px|50px|45px|true|false"][et_pb_column _builder_version="4.22.2" _module_preset="default" type="4_4" theme_builder_area="post_content"][et_pb_text _builder_version="4.22.2" _module_preset="default" theme_builder_area="post_content" hover_enabled="0" sticky_enabled="0" custom_margin="|-141px||||"]
In the hustle and bustle of our daily lives, we often overlook the subtle signs of illness that our bodies tell us, dismissing minor aches and discomforts. This tendency, however, can prove dangerous, especially when it comes to recognising the symptoms of a heart attack.
A recent survey by NHS England unveils a concerning reality - many individuals are not confident in identifying the signs of a heart attack, with the figures being notably higher among those over 55. This lack of awareness could be a matter of life and death, particularly for individuals with chronic conditions who might misattribute heart attack symptoms to their existing ailments.
The NHS England's 'Help Us, Help You' campaign calls for everyone to equip themselves with the knowledge of heart attack symptoms and act promptly by calling 999 if they suspect they or someone around them is having a heart attack.
Heart attack symptoms can be elusive and may vary from person to person. The most common symptom is chest pain, often described as a feeling of pressure, heaviness, tightness, or squeezing across the chest. However, symptoms can also manifest in other forms, such as pain in the arms, jaw, neck, back, and tummy, lightheadedness, sweating, shortness of breath, nausea, vomiting, an overwhelming feeling of anxiety, coughing or wheezing.
The narratives of heart attack survivors Asif and Gemma underscore the importance of heeding these signs. Gemma initially dismissed her symptoms as exercise-induced discomfort, while Asif mistook his for food poisoning. Their stories are a stark reminder that a delay in seeking help can result in severe heart muscle damage, impacting the quality of life post-recovery.
For individuals managing chronic conditions, it's easy to fall into a routine of attributing all discomfort to the existing ailment. This mindset, however, can obscure the onset of other serious conditions like a heart attack. Listening to your body, understanding its signals, and seeking medical attention when something feels amiss is imperative.
The campaign by NHS England also sheds light on the common confusion between heart attacks and cardiac arrests. While a heart attack is a circulation problem caused by a blockage that inhibits blood flow to the heart, a cardiac arrest is an electrical issue where the heart suddenly stops beating. Understanding this distinction is crucial as the immediate response required for each differs significantly.
The 'Help Us, Help You' campaign is more than just a slogan; it's a plea for public vigilance and a step towards fostering a culture of proactive healthcare. By educating ourselves and acting promptly, we safeguard our health and contribute to a community where timely intervention becomes a norm rather than an exception.
With over 84,000 hospital heart attack admissions in England during 2021/22, the urgency of this message cannot be overstated. Visit nhs.uk/heartattack for further information. Your prompt action could be a beacon of hope for yourself and others, ensuring that heartbeats continue to echo with vitality.
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
Understanding the UK Government's New Guidance on Damp and Mould: What It Means for Tenants and Landlords
[et_pb_section fb_built="1" theme_builder_area="post_content" _builder_version="4.22.2" _module_preset="default"][et_pb_row _builder_version="4.22.2" _module_preset="default" theme_builder_area="post_content"][et_pb_column _builder_version="4.22.2" _module_preset="default" type="4_4" theme_builder_area="post_content"][et_pb_text _builder_version="4.22.2" _module_preset="default" theme_builder_area="post_content" hover_enabled="0" sticky_enabled="0" custom_margin="-75px|-90px||-80px||" custom_padding="0px|||||"]
Understanding the UK Government's New Guidance on Damp and Mould: What It Means for Tenants and Landlords
Introduction
The UK Government has recently published a comprehensive guidance document aimed at addressing the health risks associated with damp and mould in rented homes. This guidance comes as a direct response to the tragic death of 2-year-old Awaab Ishak in 2020, who lost his life due to mould exposure in his family home. The document is a crucial step in ensuring that landlords understand their responsibilities and that tenants are protected from the health risks associated with damp and mould.
The Tragic Catalyst: Awaab Ishak
The guidance was formulated in the wake of the tragic death of Awaab Ishak, a 2-year-old who died due to mould exposure in his family home. The Coroner’s report highlighted a series of failures by the housing provider, leading to this avoidable tragedy. The guidance aims to prevent such incidents from happening again by educating landlords about their legal responsibilities and the serious health risks that damp and mould pose.
Key Messages from the Guidance
Health Risks
The guidance emphasises that damp and mould primarily affect the respiratory system but can also have detrimental effects on mental health. Vulnerable groups, such as children, older adults, and people with pre-existing health conditions, are at greater risk.
Landlord Responsibilities
Landlords are urged to respond sensitively and urgently to reports of damp and mould. They are required to tackle the underlying issues promptly without waiting for medical evidence. The guidance also stresses that tenants should not be blamed for the conditions leading to damp and mould.
Proactive Approach
The guidance encourages landlords to adopt a proactive approach to identifying and tackling damp and mould. This includes having clear processes in place, understanding the condition of their homes, and building relationships with health and social care professionals.
Legal Changes and Future Plans
The government plans to introduce several legislative changes to improve housing standards:
- 'Awaab’s Law': New requirements for landlords to address hazards like damp and mould.
- New powers for the Housing Ombudsman.
- Review of the Decent Homes Standard.
- Introduction of new professionalisation standards for housing staff.
The Significance of the Guidance
For Landlords
The guidance serves as a comprehensive manual for landlords, outlining their legal responsibilities and offering best practices. Failure to adhere to these guidelines could result in legal repercussions.
For Tenants
A Commitment to Health and Well-Being
One of the most significant aspects of the new government guidance is the assurance it provides to tenants. For many renters, particularly those in social housing or in older properties, damp and mould can be persistent issues that are often ignored or inadequately addressed by landlords. The guidance makes it clear that such negligence is not only unacceptable but also illegal. By outlining the health risks associated with damp and mould, from respiratory issues to mental health impacts, the guidance underscores the government's commitment to the health and well-being of tenants.
Empowering Tenants
The guidance serves as an empowering tool for tenants. It provides them with the information they need to understand what constitutes a safe and habitable living environment. This knowledge is crucial when it comes to holding landlords accountable for the conditions of the property. Tenants can now point to a government document that clearly outlines the responsibilities of landlords, thereby strengthening their position in any disputes over property conditions.
A Resource for Legal Recourse
The guidance is not just a set of recommendations; it is tied to legal standards and forthcoming legislation. This means that tenants have a stronger legal footing if they need to take action against a landlord who is failing to maintain a property to the required standard. For example, the introduction of 'Awaab’s Law' will set out new requirements for landlords to address hazards like damp and mould, providing tenants with a specific legal framework to refer to in case of disputes.
Encouraging Proactive Reporting
The guidance also encourages tenants to report issues of damp and mould without fear of blame or repercussions. It explicitly states that damp and mould are not the result of 'lifestyle choices' and that landlords are responsible for identifying and addressing the underlying causes. This is particularly important for tenants who may have been hesitant to report issues in the past due to fear of eviction or other forms of retaliation.
Mental Health Benefits
By addressing the issue of damp and mould, the guidance also indirectly contributes to the mental well-being of tenants. Living in a damp or mouldy home can be a significant source of stress, exacerbating existing mental health issues or contributing to new ones. Knowing that there are guidelines in place to ensure that landlords take these issues seriously can provide tenants with peace of mind.
For Healthcare Providers
Healthcare providers can also benefit from this guidance as it provides valuable information on the health risks associated with damp and mould, aiding in diagnosis and treatment.
Potential Impacts
- Improved Housing Standards: The guidance is expected to raise the bar for housing standards across the UK.
- Better Tenant-Landlord Relations: The clarity provided by the guidance could lead to improved relationships between tenants and landlords.
- Legal Accountability: Landlords are now more accountable, legally, for providing safe and habitable living conditions.
- Public Awareness: The guidance could lead to increased public awareness about the health risks associated with damp and mould.
The UK Government's new guidance on damp and mould is a significant step forward in ensuring safer and healthier living conditions in rented homes. It serves as a vital resource for landlords, tenants, and healthcare providers alike. While it is too early to measure the full impact of this guidance, it holds the promise of instigating positive changes in the UK's housing sector.
You can access a full copy of the guidance via the link below:
[/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]